AQR Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-91,733
| Closed | -$1.85M | – | 2327 |
|
|
2021
Q3 | $1.85M | Buy |
91,733
+52,741
| +135% | +$1.06M | ﹤0.01% | 1194 |
|
|
2021
Q2 | $1.46M | Sell |
38,992
-28,881
| -43% | -$1.08M | ﹤0.01% | 1403 |
|
|
2021
Q1 | $1.74M | Buy |
67,873
+9,567
| +16% | +$245K | ﹤0.01% | 1279 |
|
|
2020
Q4 | $1.28M | Sell |
58,306
-52,060
| -47% | -$1.15M | ﹤0.01% | 1389 |
|
|
2020
Q3 | $1.99M | Sell |
110,366
-20,577
| -16% | -$370K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $3.33M | Buy |
130,943
+3,612
| +3% | +$91.7K | 0.01% | 935 |
|
|
2020
Q1 | $2.34M | Buy |
127,331
+107,252
| +534% | +$1.97M | ﹤0.01% | 1016 |
|
|
2019
Q4 | $442K | Buy |
20,079
+2,372
| +13% | +$52.2K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $254K | Sell |
17,707
-21,936
| -55% | -$315K | ﹤0.01% | 1952 |
|
|
2019
Q2 | $624K | Buy |
39,643
+3,919
| +11% | +$61.7K | ﹤0.01% | 1655 |
|
|
2019
Q1 | $523K | Sell |
35,724
-14,557
| -29% | -$213K | ﹤0.01% | 1783 |
|
|
2018
Q4 | $538K | Buy |
50,281
+6,120
| +14% | +$65.5K | ﹤0.01% | 1747 |
|
|
2018
Q3 | $674K | Buy |
44,161
+983
| +2% | +$15K | ﹤0.01% | 1849 |
|
|
2018
Q2 | $529K | Buy |
+43,178
| New | +$529K | ﹤0.01% | 1963 |
|
|
2016
Q2 | – | Sell |
-41,758
| Closed | -$224K | – | 2286 |
|
|
2016
Q1 | $224K | Sell |
41,758
-50,682
| -55% | -$272K | ﹤0.01% | 2084 |
|
|
2015
Q4 | $1.1M | Buy |
92,440
+15,762
| +21% | +$187K | ﹤0.01% | 1525 |
|
|
2015
Q3 | $630K | Buy |
76,678
+32,219
| +72% | +$265K | ﹤0.01% | 1636 |
|
|
2015
Q2 | $620K | Buy |
+44,459
| New | +$620K | ﹤0.01% | 1697 |
|